RESUMEN
Objective:This study aimed to analyze and summarize the clinicopathologic characteristics and treatment protocols of large cell lung carcinoma (LCLC). Methods:Clinicopathologic data of 83 cases with LCLC confirmed by pathology in 2012 were retrospectively reviewed. Results:Exactly 83 cases of LCLC accounted for 5.4%of lung cancer in 2012. Sixty-three cases were male and twenty were female. The average age was 60.4 years old. The average maximum diameter of the tumor was 4.6 cm. The common manifestations in imageology were peripheral type. Only four cases were correctly diagnosed by sputum exfoliocytology, biopsy of bronchofibroscope, and paracentesis before surgery. Sixty-three cases (76%) underwent surgical resection, and pulmonary lobectomy was mainly selected. Postoperative pathology diagnosis indicated that 39 cases were classic large cell carcinoma, 31 were large cell neu-roendocrine carcinoma, 2 were combined large cell neuroendocrine carcinoma, 8 were basaloid carcinoma, 2 were clear cell carcinoma, and 1 was lymphoepithelioma-like carcinoma. Each subtype of LCLC had respective characteristics of pathomorphology and immuno-histochemistry. Lymph node metastasis occurred in 62 cases (75%). Conclusion:The incidence rate of LCLC, which is a highly aggres-sive malignancy, is low. The clinical manifestation and imageology characteristics of LCLC do not have specificity, and its final diagno-sis depends on pathology diagnosis. Operation is the main treatment method. Improving the diagnosis rate of LCLC and further subdi-viding the pathological subtypes are important for a normalized comprehensive treatment of LCLC.
RESUMEN
Objective To explore the relationship between hypermethylation and expression of cadherin 1(CDH1)with lung cancer.Methods The semi-quantitative real-time methylation specific polymerage chsin reaction(MSP)were used to detect the promoter's relative methylation ratio of CDH1 in all 30 cases of lung cancer tissues,para-cancer lung tissues,distal lung tissues and 5 non-cancer lung tissue samples.Nested RT-PCR was used to detect the expression ratio of CDH1 mRNA.The western blot analysis was used to detect the expression of E-cad protein.The immunohistoeheroical method was used to confirm some negative results of western blot analysis.Results The relative methylation ratios was 0.13%-450.67%(median:33.61%)in cancer tissues,0.00%-177.02%(median:18.04%)in para-cancer tissues,and 0.00%-51.68%(median:13.69%)in far-cancer tissues.Statistical significance between cancer and pars-cancer tissues(Z=-2.355,P＜0.05)and between cancer and disial tissues(Z=-3.527,P＜0.01)were found.The results of nested RT-PCR showed that there were statistical sigaificance of mRNA expression between lung cancer tissues and pars-cancer tissues,distal lung tissues or non-cancer lung tissues(F=9.081,P＜0.01).The results of western blot showed that the positive expression rate of E-cad was 36.7% in lung cancer tissues,70.0%in para-cancer tissues,and 96.7% in far-cancer lung tissues,respectively.There was a statistical significance of positive rate pf E-cad expression between lung cancer tissues and pars-cancer tissues or diatal tissues(X2=6.70,24.30,7.68,P＜0.01).Conclusions The study showed that transcription of CDH1 mRNA would be silenced by hypermethylation of CDH1 promoter,resulting in the decreased expression of E-cad.The aberrant hypermethylation of E-cad is implicated in lung cancer.
RESUMEN
<p><b>BACKGROUND</b>Gejiu in Yunnan Province is a region where the incidence of lung cancer is high among the miners of tin mine. Our previous research team successfully induced the malignant transformation of immortalized human bronchial epithelial cells (BEAS-2B) by Gejiu mineral powder in vitro. The objective of this study is to explore the role of survivin and proliferating cell nuclear antigen (PCNA) in the pathway of the malignant transformation of BEAS-2B induced by Gejiu mineral powder.</p><p><b>METHODS</b>Protein expression of survivn and PCNA in BEAS-2B cells and its malignant transformation cells was respectively evaluated by immunofluorescence cytochemistry staining technique and immunohistochemistry.</p><p><b>RESULTS</b>(1)The expression of survivin protein was negative in BEAS-2B cells and was positive in its malignant transformation cells by immunofluorescence cytochemistry staining techniques. And the protein level of PCNA was low in BEAS-2B cells and high in its malignant transformation cells. (2)The positive expression of survivin protein in BEAS-2B cells (0/20) was significantly lower than that in its malignant transformation cells (85%, 17/20) by immunohistochemistry (P < 0.001). And the labelling index (LI) of PCNA in BEAS-2B cells was significantly lower than that in its malignant transformation cells (P < 0.001). LI of PCNA in the malignant transformation cells of BEAS-2B with positive expression of survivin was significantly higher than that with negative expression of survivin (P < 0.001).</p><p><b>CONCLUSIONS</b>(1)The up-regulation expression of survivin in malignant transforma- tion cells of BEAS-2B suggests that survivin may play an important role in the pathway of malignant transformation in BEAS-2B cells induced by Gejiu mineral powder. It may give a proof for revealing the carcinogenesis of lung cancer in Gejiu miner. Survivin may be identified as a novel potential diagnostic and therapeutic target of lung cancer in Gejiu miner. (2)The up-regulation expression of PCNA in malignant transformation cells of BEAS-2B suggests that cell proliferation may play an important role in the pathway of malignant transformation. (3)Survivin may promote cell proliferation mediated by PCNA. Survivn and PCNA may play synergetic roles in the process of malignant transformation in BEAS-2B cells induced by Gejiu mineral powder.</p>